Diurnal Intraocular Pressure Efficacy of the Timolol-Brimonidine Fixed Combination and the Timolol-Dorzolamide Fixed Combination as a First Choice Therapy in Patients with Pseudoexfoliation Glaucoma


YÜKSEL N., Gok M., Altintas O. , Caglar Y.

CURRENT EYE RESEARCH, vol.36, no.9, pp.804-808, 2011 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 36 Issue: 9
  • Publication Date: 2011
  • Doi Number: 10.3109/02713683.2011.584651
  • Title of Journal : CURRENT EYE RESEARCH
  • Page Numbers: pp.804-808

Abstract

Purpose: To evaluate the 6-month daytime efficacy of a fixed combination of timolol and brimonidine (BTFC) versus a timolol and dorzolamide fixed combination (DTFC) as a first choice therapy in patients with pseudoexfoliation glaucoma (PXG).